These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29733583)

  • 21. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
    Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
    J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
    Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
    J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.
    Ren J; Zhu X; Xu P; Li R; Fu Y; Dong S; Zhangsun D; Wu Y; Luo S
    Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30823399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
    Yu R; Kompella SN; Adams DJ; Craik DJ; Kaas Q
    J Med Chem; 2013 May; 56(9):3557-67. PubMed ID: 23566299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Conformationally Constrained α-RgIA Analogues as Stable Peptide Antagonists of Human α9α10 Nicotinic Acetylcholine Receptors.
    Zheng N; Christensen SB; Blakely A; Dowell C; Purushottam L; McIntosh JM; Chou DH
    J Med Chem; 2020 Aug; 63(15):8380-8387. PubMed ID: 32597184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor.
    Ning J; Li R; Ren J; Zhangsun D; Zhu X; Wu Y; Luo S
    Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30551685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
    Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
    Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
    Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
    Nevin ST; Clark RJ; Klimis H; Christie MJ; Craik DJ; Adams DJ
    Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-Activity Studies Reveal the Molecular Basis for GABA
    Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
    ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of α9α10 Nicotinic Receptors With Peptides and Proteins From Animal Venoms.
    Tsetlin V; Haufe Y; Safronova V; Serov D; Shadamarshan P; Son L; Shelukhina I; Kudryavtsev D; Kryukova E; Kasheverov I; Nicke A; Utkin Y
    Front Cell Neurosci; 2021; 15():765541. PubMed ID: 35002625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
    McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
    Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.
    Wu RJ; Wang L; Xiang H
    Curr Top Med Chem; 2015; 16(2):156-69. PubMed ID: 26126912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors.
    Wu Y; Zhangsun D; Zhu X; Kaas Q; Zhangsun M; Harvey PJ; Craik DJ; McIntosh JM; Luo S
    J Med Chem; 2017 Jul; 60(13):5826-5833. PubMed ID: 28603989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solving the alpha-conotoxin folding problem: efficient selenium-directed on-resin generation of more potent and stable nicotinic acetylcholine receptor antagonists.
    Muttenthaler M; Nevin ST; Grishin AA; Ngo ST; Choy PT; Daly NL; Hu SH; Armishaw CJ; Wang CI; Lewis RJ; Martin JL; Noakes PG; Craik DJ; Adams DJ; Alewood PF
    J Am Chem Soc; 2010 Mar; 132(10):3514-22. PubMed ID: 20163143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dicarba α-conotoxin Vc1.1 analogues with differential selectivity for nicotinic acetylcholine and GABAB receptors.
    van Lierop BJ; Robinson SD; Kompella SN; Belgi A; McArthur JR; Hung A; MacRaild CA; Adams DJ; Norton RS; Robinson AJ
    ACS Chem Biol; 2013 Aug; 8(8):1815-21. PubMed ID: 23768016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspartic acid mutagenesis of αO-Conotoxin GeXIVA isomers reveals arginine residues crucial for inhibition of the α9α10 nicotinic acetylcholine receptor.
    Luo A; He J; Yu J; Wu Y; Harvey PJ; Kasheverov IE; Kudryavtsev DS; McIntosh JM; Tsetlin VI; Craik DJ; Zhangsun D; Luo S
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132472. PubMed ID: 38772455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of Action and Structure-Activity Relationship of α-Conotoxin Mr1.1 at the Human α9α10 Nicotinic Acetylcholine Receptor.
    Liang J; Tae HS; Zhao Z; Li X; Zhang J; Chen S; Jiang T; Adams DJ; Yu R
    J Med Chem; 2022 Dec; 65(24):16204-16217. PubMed ID: 36137181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.
    AlSharari SD; Toma W; Mahmood HM; Michael McIntosh J; Imad Damaj M
    Eur J Pharmacol; 2020 Sep; 883():173320. PubMed ID: 32645334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational and Functional Mapping of Human and Rat α6β4 Nicotinic Acetylcholine Receptors Reveals Species-Specific Ligand-Binding Motifs.
    Hone AJ; Kaas Q; Kearns I; Hararah F; Gajewiak J; Christensen S; Craik DJ; McIntosh JM
    J Med Chem; 2021 Feb; 64(3):1685-1700. PubMed ID: 33523678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.